In a report released today, David Risinger from Morgan Stanley maintained a Hold rating on Perrigo Company plc (PRGO), with a price target of $54. The company’s shares closed yesterday at $46.77.
According to TipRanks.com, Risinger ‘s ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -8.9% and a 40.2% success rate. Risinger covers the Healthcare sector, focusing on stocks such as Bausch Health Companies Inc, Elanco Animal Health Inc, and Jazz Pharmaceuticals.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Perrigo Company plc with a $67.33 average price target, a 44.0% upside from current levels. In a report issued on March 15, RBC Capital also reiterated a Hold rating on the stock with a $48 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $84.94 and a one-year low of $36.28. Currently, Perrigo Company plc has an average volume of 1.56M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals.
